[go: up one dir, main page]

NO851564L - Fremstilling av polypeptider med human-gamma-interferon-aktivitet. - Google Patents

Fremstilling av polypeptider med human-gamma-interferon-aktivitet.

Info

Publication number
NO851564L
NO851564L NO851564A NO851564A NO851564L NO 851564 L NO851564 L NO 851564L NO 851564 A NO851564 A NO 851564A NO 851564 A NO851564 A NO 851564A NO 851564 L NO851564 L NO 851564L
Authority
NO
Norway
Prior art keywords
human
polypeptides
preparation
sequences
gamma interferon
Prior art date
Application number
NO851564A
Other languages
English (en)
Other versions
NO171983B (no
NO171983C (no
Inventor
Joachim Engels
Michael Leineweber
Wolfgang Ulmer
Eugen Uhlmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO851564L publication Critical patent/NO851564L/no
Publication of NO171983B publication Critical patent/NO171983B/no
Publication of NO171983C publication Critical patent/NO171983C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO851564A 1984-04-19 1985-04-18 Fremstilling av polypeptider med human-gammainterferon-aktivitet og dna-sekvens derav NO171983C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843414831 DE3414831A1 (de) 1984-04-19 1984-04-19 Herstellung von polypeptiden mit human-gammainterferon-aktivitaet

Publications (3)

Publication Number Publication Date
NO851564L true NO851564L (no) 1985-10-21
NO171983B NO171983B (no) 1993-02-15
NO171983C NO171983C (no) 1993-05-26

Family

ID=6234006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851564A NO171983C (no) 1984-04-19 1985-04-18 Fremstilling av polypeptider med human-gammainterferon-aktivitet og dna-sekvens derav

Country Status (20)

Country Link
US (1) US4832959A (no)
EP (1) EP0161504B1 (no)
JP (2) JPH0745516B2 (no)
KR (1) KR920009505B1 (no)
AT (1) ATE69241T1 (no)
CA (1) CA1339892C (no)
DE (2) DE3414831A1 (no)
DK (1) DK164940C (no)
ES (1) ES542337A0 (no)
FI (1) FI90436C (no)
GR (1) GR850941B (no)
HU (1) HU210111B (no)
IE (1) IE59460B1 (no)
IL (1) IL74947A (no)
MA (1) MA20411A1 (no)
NO (1) NO171983C (no)
NZ (1) NZ211827A (no)
PH (1) PH25251A (no)
PT (1) PT80300B (no)
ZA (1) ZA852900B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
US5157004A (en) * 1986-12-27 1992-10-20 Takeda Chemical Industries, Ltd. Polypeptides and production thereof
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
EP1231943A1 (en) 1999-11-12 2002-08-21 Maxygen Holdings Ltd Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
EP1539814A2 (en) * 2002-07-03 2005-06-15 Maxygen Holdings Ltd. c/o Close Brothers (Cayman) Limited Full-length interferon gamma polypeptide variants
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
CA2607806A1 (en) * 2005-05-04 2006-11-16 Nautilus Biotech, S.A. Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
WO2008121461A2 (en) * 2007-02-26 2008-10-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Vaccine for activating helper function of cd8+ tcells
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
JP4821891B2 (ja) * 2009-07-01 2011-11-24 トヨタ自動車株式会社 電池制御システム及び車両
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
CN113166261A (zh) 2018-10-11 2021-07-23 印希比股份有限公司 B7h3单域抗体及其治疗性组合物
TW202028245A (zh) 2018-10-11 2020-08-01 美商英伊布里克斯公司 Dll3單域抗體及其治療性組合物
US11208485B2 (en) 2018-10-11 2021-12-28 Inhibrx, Inc. PD-1 single domain antibodies and therapeutic compositions thereof
TW202506736A (zh) 2018-10-11 2025-02-16 美商因荷布瑞克斯生物科學公司 5t4單域抗體及其治療性組合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
ES8603574A1 (es) 1985-12-16
JPH06153957A (ja) 1994-06-03
DK164940C (da) 1993-02-01
HU210111B (en) 1995-02-28
ATE69241T1 (de) 1991-11-15
IL74947A (en) 2000-06-01
DE3414831A1 (de) 1985-10-31
FI851529A0 (fi) 1985-04-17
GR850941B (no) 1985-11-25
ES542337A0 (es) 1985-12-16
JPH07100037B2 (ja) 1995-11-01
EP0161504A1 (de) 1985-11-21
DK164940B (da) 1992-09-14
FI90436C (fi) 1994-02-10
DE3584579D1 (de) 1991-12-12
EP0161504B1 (de) 1991-11-06
PH25251A (en) 1991-03-27
NO171983B (no) 1993-02-15
KR850007274A (ko) 1985-12-02
KR920009505B1 (ko) 1992-10-17
US4832959A (en) 1989-05-23
IE59460B1 (en) 1994-02-23
JPH0745516B2 (ja) 1995-05-17
ZA852900B (en) 1985-11-27
CA1339892C (en) 1998-06-02
DK176285A (da) 1985-10-20
PT80300A (de) 1985-05-01
HUT37815A (en) 1986-02-28
IE850995L (en) 1985-10-19
FI851529L (fi) 1985-10-20
MA20411A1 (fr) 1985-12-31
NZ211827A (en) 1988-07-28
DK176285D0 (da) 1985-04-18
IL74947A0 (en) 1985-08-30
NO171983C (no) 1993-05-26
JPS60233100A (ja) 1985-11-19
FI90436B (fi) 1993-10-29
PT80300B (pt) 1987-09-30

Similar Documents

Publication Publication Date Title
NO851564L (no) Fremstilling av polypeptider med human-gamma-interferon-aktivitet.
FI853056A0 (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
FI103731B (fi) Uusia, tekijä VIII-aktiivisuutta omaavia proteiineja koodittava DNA-sekvenssi ja menetelmä näiden proteiinien valmistamiseksi
EP0174367A4 (en) HOSTS AND METHODS FOR PRODUCING RECOMBINANT PRODUCTS IN LARGE QUANTITIES.
IL88223A0 (en) Polypeptides,process,nucleotide sequences,expression vectors and host organisms for their production and pharmaceutical compositions comprising them
EP0226448A3 (en) Solubilisation of protein aggregates
GB8912330D0 (en) Live vaccines
EP0237966A3 (en) Human basic fibroblast growth factor
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
PT80542A (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
ATE111521T1 (de) Polypeptid und dessen herstellung.
EP0315118A3 (en) Dna coding for endothelin and use thereof
ES543120A0 (es) Procedimiento para preparar polipeptidos a partir de aminoa-cidos geneticamente codificables
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
KR890002399A (ko) 하이브리드 인터페론 및 재조합 dna기술을 이용한 그의 제조방법
IE872531L (en) Preparation of salmon calcitonin by genetic engineering, and¹means for carrying out this process

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2002